The Phoenix Healthcare research teams partner with clients throughout the world to help better predict, manage and influence the healthcare decisions of physicians, payors and patients. Our research offerings are uniquely designed to meet the needs that arise throughout the commercialization process—from clinical discovery to launch, and accelerated growth to generic competition. Our clients span a broad customer base that includes pharmaceutical, biotech, device and diagnostics as well as healthcare organizations in both the U.S. and internationally.
Clients subscribe to Phoenix Healthcare's monthly, bi-monthly, and quarterly Syndicated Research Studies to track product/service usage and intentions, purchase behavior, brand perceptions, advertising and publicity impact, competitive activities, and consumer lifestyles.
U.S. Domestic
Phoenix Healthcare provides custom-designed marketing research solutions for U.S. pharmaceutical and healthcare customers. The Healthcare team will work directly with you to design custom studies with two key objectives—first, to deliver actionable marketing programs and, second, to impact your bottom line. The team’s specific expertise centers on physician needs and evolving behavioral trends within the context of increased patient influence and reimbursement restriction.
The results of each study reveal key segments to target, drivers that motivate purchase decisions and differentiators for your brand. Designed to link research insights to performance data, our quantitative studies show clients where opportunities exist to grow revenue, either in the marketplace or within their customer base.
Phoenix Healthcare’s unique qualitative research techniques uncover new insights and unmet needs.
Phoenix Healthcare has developed an advertising/communication audit and performance evaluation system founded on large-scale, syndicated industry tracking studies known as AdPi® and BrandPi® Audits (Advertising Performance Index and Brand Performance Index).
Audits covering the Top 10 DTC Pharmaceutical categories by media spending are being launched every quarter. The Cardiology/Cholesterol Audit and Women’s Contraceptive Audit were launched in 2008 and the Autoimmune Audit was launched in 2011. These studies track brand awareness, brand knowledge, usage, and measures which ads and media are generating the highest response for the money.
Our International team, residing in both the U.S. and Europe, provides proven qualitative and quantitative research findings on various types of studies, including customer satisfaction with both HCPs and patients, global positioning, market landscape, segmentation, pricing, patient records-based research, A+U and market potential via advanced analytics. This truly dedicated team solely works on international projects for clients in the pharmaceutical and healthcare industry.
